Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cells

PLoS One. 2014 Apr 17;9(4):e95566. doi: 10.1371/journal.pone.0095566. eCollection 2014.

Abstract

The airway epithelium may release pro-inflammatory cytokines and chemokines in the asthmatic airway. Sphingosine 1-phosphate (S1P) is a bioactive lipid, increased in the airways of asthmatics, that may trigger the release of the potent neutrophil chemoattractant Interleukin-8 (IL-8) by epithelial cells. S1P is a ligand for 5 G protein-coupled receptors, S1PR1-5. We wished to explore the mechanisms of S1P induced IL-8 secretion with regard to the receptor(s) and downstream signaling events involved. Our results indicate that S1P induced IL-8 release is mediated by S1PR2 and the transcription factor NF-κB. Since the Epidermal Growth Factor Receptor (EGFR) and reactive oxygen species (ROS) have been implicated in IL-8 release in response to activation of other G protein-coupled receptors, we examined their importance in S1P induced IL-8 release and established that they are not involved. This study reveals S1PR2 and NF-κB as potential therapeutic targets in neutrophilic airway diseases such as severe asthma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • ErbB Receptors / metabolism
  • Humans
  • Interleukin-8 / metabolism*
  • Lysophospholipids / pharmacology*
  • NF-kappa B / metabolism*
  • Reactive Oxygen Species / metabolism
  • Receptors, Lysosphingolipid / metabolism*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology

Substances

  • Interleukin-8
  • Lysophospholipids
  • NF-kappa B
  • Reactive Oxygen Species
  • Receptors, Lysosphingolipid
  • sphingosine 1-phosphate
  • EGFR protein, human
  • ErbB Receptors
  • Sphingosine